Search - tctmd.com

Displaying 121 - 140 of 201

Sort: Relevancy | Date

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

News Daily News

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Todd Neale

October 10, 2014

News Daily News

Registro MARIS: El Stent de Nitinol Parece Seguro y Efectivo en Pacientes AFS del ‘Mundo Real’

October 03, 2014

News Daily News

MARIS登记处：镍钛合金支架对“真实”SFA患者安全、有效

October 03, 2014

News Daily News

MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients

October 03, 2014

News Industry News

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

News Industry News

BIOTRONIK Announces First Enrollments to BIOFLEX PEACE Registry

July 10, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Industry News

PEACE I All Comers Registry Results Demonstrate Efficacy of BIOTRONIK Pulsar-18 Self-Expanding Stent

June 13, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Daily News

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

May 30, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

Advertisement

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Registro MARIS: El Stent de Nitinol Parece Seguro y Efectivo en Pacientes AFS del ‘Mundo Real’

MARIS登记处：镍钛合金支架对“真实”SFA患者安全、有效

MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

BIOTRONIK Announces First Enrollments to BIOFLEX PEACE Registry

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

PEACE I All Comers Registry Results Demonstrate Efficacy of BIOTRONIK Pulsar-18 Self-Expanding Stent

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

EuroPCR Features PAD Therapies in Early Development and Real-World Use

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content